Millipore Completes Kankakee Upgrade

The first phase of Millipore Corp.’s plant modernization project is complete at its facility in Kankakee, IL. The plant manufactures certain key products including Probumin brand Bovine Serum Albumin and other products derived from bovine serum or plasma.

The project included installation of new, state-of-the-art-control and processing equipment, helping the company to enhance control over product quality and existing proprietary and validated processes. Critical equipment was replaced with modern equivalents of the same configuration and processing characteristics, so there will be no change in the reactivity or other characteristics of the affected products. This initiative does not impact the Ex-Cyte focus factory also located at the Kankakee facility.

“This modernization to our Kankakee processing plant demonstrates Millipore’s commitment to delivering the highest product quality through enhanced process control to meet the on-going needs of our life science customers,” said Andrew Bulpin Ph.D, vice president of Millipore’s Bio-Products and Technologies Business Unit. “Our many customers expect Millipore to maintain leadership in the area.”

Phase 2 of the modernization project will begin immediately and will include enhancements to plant capacity and to filling and packaging capabilities.